-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeSci Capital Initiates Coverage On Molecular Partners with Outperform Rating, Announces Price Target of $12

Benzinga·03/11/2025 12:44:52
Listen to the news
LifeSci Capital initiates coverage on Molecular Partners (NASDAQ:MOLN) with a Outperform rating and announces Price Target of $12.